Cardiol Therapeutics Inc. Class A Common Shares (CRDL)
CRDL trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.20
+1.70% on the day
Market cap
$144.8M
Micro cap
Revenue
No annual revenue filed since the period ending 2021-12-31
Net income
No annual revenue filed since the period ending 2021-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CRDL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001702123 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | A6 |
Financials
No annual revenue filed since the period ending 2021-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-03-31 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-09-23 |
Source: SEC EDGAR submissions feed, 185 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MOLN | Molecular Partners AG | $3.67 | -3.17% | $137.7M |
| OTLK | Outlook Therapeutics Inc. | $0.5638 | -3.64% | $137.3M |
| AVXL | Anavex Life Sciences Corp. | $1.48 | -1.99% | $137.2M |
| CMPX | Compass Therapeutics Inc. | $0.8570 | -8.59% | $154.3M |
| TARA | Protara Therapeutics Inc. | $2.62 | -5.42% | $154.8M |
| VYGR | Voyager Therapeutics Inc. | $2.15 | -5.29% | $132.5M |
| ABOS | Acumen Pharmaceuticals Inc. | $1.81 | -10.15% | $131.3M |
| IPHA | Innate Pharma S.A. ADS | $1.47 | -0.68% | $164.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier